Sexcord/ stromal ovarian tumors risk factors

Jump to navigation Jump to search

Sexcord/ stromal ovarian tumors Microchapters


Patient Information


Historical Perspective




Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound

CT scan


Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sexcord/ stromal ovarian tumors risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors risk factors

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sexcord/ stromal ovarian tumors risk factors

CDC on Sexcord/ stromal ovarian tumors risk factors

Sexcord/ stromal ovarian tumors risk factors in the news

Blogs on Sexcord/ stromal ovarian tumors risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Sexcord/ stromal ovarian tumors risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  ; Maneesha Nandimandalam, M.B.B.S.[2]


Common risk factors in the development of sexcord/ stromal ovarian tumors include preterm birth, high gonadotrophin levels, increasing age at first pregnancy, obese and non-white women

Risk Factors

There is very little data regarding the risk factors of sexcord-stromal ovarian tumors, however given below are some of the important risk factors for the development of sexcord-stromal ovarian tumors:[1][2][3][4][5]


  1. Sieh W, Sundquist K, Sundquist J, Winkleby MA, Crump C (May 2014). "Intrauterine factors and risk of nonepithelial ovarian cancers". Gynecol. Oncol. 133 (2): 293–7. doi:10.1016/j.ygyno.2014.02.007. PMC 4006291. PMID 24530563.
  2. Chen T, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, Kaaks R, Koskela P, Grankvist K, Hallmans G, Pukkala E, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Lukanova A (February 2011). "Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer". Cancer Epidemiol. Biomarkers Prev. 20 (2): 324–36. doi:10.1158/1055-9965.EPI-10-0857. PMC 3082204. PMID 21177423.
  3. Horn-Ross PL, Whittemore AS, Harris R, Itnyre J (November 1992). "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group". Epidemiology. 3 (6): 490–5. PMID 1329996.
  4. Greggi S, Parazzini F, Paratore MP, Chatenoud L, Legge F, Mancuso S, La Vecchia C (October 2000). "Risk factors for ovarian cancer in central Italy". Gynecol. Oncol. 79 (1): 50–4. doi:10.1006/gyno.2000.5909. PMID 11006030.
  5. Zheng G, Yu H, Kanerva A, Försti A, Sundquist K, Hemminki K (2018). "Familial risks of ovarian cancer by age at diagnosis, proband type and histology". PLoS ONE. 13 (10): e0205000. doi:10.1371/journal.pone.0205000. PMC 6169923. PMID 30281663.
  6. Boyce EA, Costaggini I, Vitonis A, Feltmate C, Muto M, Berkowitz R, Cramer D, Horowitz NS (November 2009). "The epidemiology of ovarian granulosa cell tumors: a case-control study". Gynecol. Oncol. 115 (2): 221–5. doi:10.1016/j.ygyno.2009.06.040. PMID 19664811.

Template:WH Template:WS